Texas Oncology is a network of 460+ physicians and oncology specialists who provide advanced treatment options (technology, clinical trials, and research) to cancer patients in underserved rural and urban communities throughout Texas, with one office in New Mexico and one in Oklahoma. More than 68,000 patients are treated within the Texas Oncology network annually. [1]
A physician, medical practitioner, medical doctor, or simply doctor, is a professional who practises medicine, which is concerned with promoting, maintaining, or restoring health through the study, diagnosis, prognosis and treatment of disease, injury, and other physical and mental impairments. Physicians may focus their practice on certain disease categories, types of patients, and methods of treatment—known as specialities—or they may assume responsibility for the provision of continuing and comprehensive medical care to individuals, families, and communities—known as general practice. Medical practice properly requires both a detailed knowledge of the academic disciplines, such as anatomy and physiology, underlying diseases and their treatment—the science of medicine—and also a decent competence in its applied practice—the art or craft of medicine.
Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass" and the word λόγος (logos), meaning "study".
Cancer can be treated by surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy and synthetic lethality. The choice of therapy depends upon the location and grade of the tumor and the stage of the disease, as well as the general state of the patient. Cancer_genome_sequencing helps in determining which cancer the patient exactly has for determining the best therapy for the cancer. A number of experimental cancer treatments are also under development. Under current estimates, two in five people will have cancer at some point in their lifetime.
Texas Oncology doctors treat cancer, blood disorders, and related chronic diseases and specialize in medical oncology, hematology, gynecologic oncology, pediatric hematology/oncology, radiation oncology, breast, and urology care.
A chronic condition is a human health condition or disease that is persistent or otherwise long-lasting in its effects or a disease that comes with time. The term chronic is often applied when the course of the disease lasts for more than three months. Common chronic diseases include arthritis, asthma, cancer, chronic obstructive pulmonary disease, diabetes and some viral diseases such as hepatitis C and acquired immunodeficiency syndrome. An illness which is lifelong because it ends in death is a terminal illness. It is possible and not unexpected for an illness to change in definition from terminal to chronic. Diabetes and HIV for example were once terminal yet are now considered chronic due to the availability of insulin and daily drug treatment for individuals with HIV which allow these individuals to live while managing symptoms.
Hematology, also spelled haematology, is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. It involves treating diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. Such diseases might include hemophilia, blood clots, other bleeding disorders and blood cancers such as leukemia, multiple myeloma, and lymphoma. The laboratory work that goes into the study of blood is frequently performed by a medical technologist or medical laboratory scientist.
Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they have extensive training in the diagnosis and treatment of these cancers.
Roswell Park Comprehensive Cancer Center is a cancer research and treatment center and a New York State public-benefit corporation located in Buffalo, New York and founded by Roswell Park. Candace S. Johnson is President & Chief Executive Officer of Roswell Park Comprehensive Cancer Center. In 2018, Roswell Park ranked #30 on U.S. News & World Report's list of the best cancer hospitals in the country. Roswell Park was the first dedicated medical facility for cancer treatment and research in the United States, and is the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center." Roswell Park Comprehensive Cancer Center, which conducts clinical research on cancer as well as developing new drugs, provides advanced treatment for all forms of adult and pediatric cancer and serves as a member of the National Comprehensive Cancer Network.
Chandler Park is an American physician, medical journalist, and clinical researcher. Park contributes regularly as an expert physician for popular newspapers and magazines such as Newsweek, Reader's Digest, U.S. News & World Report, The Exponent-Telegram, College of St. Scholastica, and Medscape. He writes medical news for Doximity an online medical social network that includes over 1,000,000 clinicians. Park is a clinical professor that teaches at the University of Louisville School of Medicine. He has also been recognized by the American Registry company with patient care awards in Patient's choice and Compassionate Doctor.
The Norris Cotton Cancer Center is a comprehensive cancer center as designated by the National Cancer Institute, with administrative offices located within the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.
Geriatric oncology is a branch of medicine that is concerned with the diagnosis and treatment of cancer in the elderly, usually defined as aged 65 and older. This fairly young but increasingly important subspecialty incorporates the special needs of the elderly into the treatment of cancer.
Texas Children's Cancer and Hematology Centers is one of the largest pediatric oncology and blood disease center in the United States. The 2019-2020 edition of U.S. News & World Report ranked Texas Children's Hospital among the top 3 best children's hospitals in the United States and #3 in the subspecialty of pediatric cancer. It is located in Houston, Texas.
Lenvatinib is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.
William K. Oh, is an American medical oncologist and expert in the management of genitourinary malignancies, including prostate, renal, bladder and testicular cancers.
Tower Cancer Research Foundation (TCRF) is a 501(c)3 non-profit organization dedicated to clinical research, patient support and community education. It was established in 1996 in Beverly Hills, California.
Naoto T Ueno is a Professor of Medicine at The University of Texas MD Anderson Cancer Center; his research is in the area of inflammatory breast cancer and the molecular mechanism of metastasis and tumorigenicity. Ueno is also affiliated with the Keio University as a visiting professor.
High-dose chemotherapy and bone marrow transplant (HDC/BMT), also high-dose chemotherapy with autologous bone marrow transplant, was a treatment regimen for metastatic breast cancer, and later high-risk breast cancer, that was considered promising during the 1980s and 1990s. It was ultimately determined to be no more effective than normal treatment, and to have significantly higher side effects, including treatment-related death.
Eric P. Winer is chief of the Division of Women's Cancers and director of the Breast Oncology Program in the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute in Boston, Massachusetts. He also serves as the Institute's chief strategy officer. He is the Thompson Senior Investigator in Breast Cancer Research and a Professor of Medicine at Harvard Medical School. Winer is a medical oncologist and clinical researcher specializing in breast cancer. He has focused his career on treating patients with breast cancer and advancing understanding of the disease. He is committed to delivering the best care to his patients today while striving to improve the methods of care for the future.
James D. Bearden III, M.D. F.A.C.P. is a native of South Carolina, a medical oncologist and current Vice President and Clinical Research & Physician Manager of the Gibbs Cancer Center & Research Institute in Spartanburg, South Carolina. Bearden is nationally recognized for his extensive involvement in the advancement of research and treatment for cancer.
Seattle Cancer Care Alliance (SCCA) is a cancer treatment and research center in Seattle, Washington. Established in 1998, this nonprofit provides clinical oncology care for patients treated at its three partner organizations: Fred Hutchinson Cancer Research Center, Seattle Children's and UW Medicine. Together, these four institutions form the Fred Hutch/University of Washington Cancer Consortium.
Thomas E. Hutson is an American medical oncologist and cancer researcher based in Dallas, Texas. He is the director of Genitourinary Oncology Program and co-director of the Urologic Cancer Research and Treatment Center at Baylor University Medical Center. He is a Professor of Medicine at the Texas A&M Health Science Center College of Medicine and serves as a chair of Genitourinary Research for US Oncology and McKesson.
Sandra M. Swain is an American oncologist, breast cancer specialist and clinical translational researcher. She is currently a professor of Medicine at the Georgetown University School of Medicine and the Associate Dean for Research Development at Georgetown University Medical Center (GUMC) and MedStar Health as well as an adjunct professor of Medicine at the F. Edward Hébert School of Medicine of the Uniformed Services University of Health Sciences. She is also a past President of the American Society of Clinical Oncology (ASCO), serving from 2012 through 2013.
Sonja Eva Singletary was an American surgeon who specialized in the care of breast cancer. She was a faculty member at the University of Texas MD Anderson Cancer Center and a past president of the Society of Surgical Oncology.
Tucatinib is an experimental small molecule inhibitor of HER2 in development for the treatment of cancer. It is an investigational drug for HER2-positive breast cancer. It was developed by Array BioPharma and licensed to Cascadian Therapeutics.
Catherine Naliaka Nyongesa Watta, is a Kenyan physician and radiation oncologist, who is the founder, owner and chief executive of Texas Cancer Centre, in Nairobi, the capital and largest city in the county.
